202 related articles for article (PubMed ID: 31561960)
21. Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.
Dionne A; Burns JC; Dahdah N; Tremoulet AH; Gauvreau K; de Ferranti SD; Baker AL; Son MB; Gould P; Fournier A; Newburger JW; Friedman KG
Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31048414
[TBL] [Abstract][Full Text] [Related]
22. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
[TBL] [Abstract][Full Text] [Related]
23. Cardiology patient pages. Kawasaki disease.
Baker AL; Newburger JW
Circulation; 2008 Aug; 118(7):e110-2. PubMed ID: 18695195
[No Abstract] [Full Text] [Related]
24. Usefulness and safety of anakinra in refractory Kawasaki disease complicated by coronary artery aneurysm.
Guillaume MP; Reumaux H; Dubos F
Cardiol Young; 2018 May; 28(5):739-742. PubMed ID: 29455693
[TBL] [Abstract][Full Text] [Related]
25. Cardiac Events and the Maximum Diameter of Coronary Artery Aneurysms in Kawasaki Disease.
Tsuda E; Tsujii N; Hayama Y
J Pediatr; 2017 Sep; 188():70-74.e1. PubMed ID: 28662948
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
[TBL] [Abstract][Full Text] [Related]
27. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline
Son MBF; Gauvreau K; Kim S; Tang A; Dedeoglu F; Fulton DR; Lo MS; Baker AL; Sundel RP; Newburger JW
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566299
[TBL] [Abstract][Full Text] [Related]
28. The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease.
Ma S; Choi SY; Ahn HJ; Siu AM; Melish ME; Bratincsak A
J Pediatr; 2020 Mar; 218():72-77.e1. PubMed ID: 31810628
[TBL] [Abstract][Full Text] [Related]
29. Kawasaki disease in infants less than one year of age.
Rosenfeld EA; Corydon KE; Shulman ST
J Pediatr; 1995 Apr; 126(4):524-9. PubMed ID: 7699529
[TBL] [Abstract][Full Text] [Related]
30. Distribution of Kawasaki Disease Coronary Artery Aneurysms and the Relationship to Coronary Artery Diameter.
Tsuda E; Tsujii N; Kimura K; Suzuki A
Pediatr Cardiol; 2017 Jun; 38(5):932-940. PubMed ID: 28321483
[TBL] [Abstract][Full Text] [Related]
31. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
Williams RV; Wilke VM; Tani LY; Minich LL
Pediatrics; 2002 Jan; 109(1):E4. PubMed ID: 11773572
[TBL] [Abstract][Full Text] [Related]
32. Effect of dipyridamole on the blood flow in coronary aneurysms resulting from Kawasaki disease.
Kobayashi T; Sone K
Pediatr Cardiol; 1994; 15(6):263-7. PubMed ID: 7838798
[TBL] [Abstract][Full Text] [Related]
33. [Incomplete Kawasaki syndrome with a coronary artery aneurysm in an infant].
Vinding RK; Debes NM; Stantchev H; Vrang C; Orngreen MC
Ugeskr Laeger; 2014 Jun; 176(25):. PubMed ID: 25352282
[TBL] [Abstract][Full Text] [Related]
34. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of coronary arterial aneurysm in Kawasaki disease.
Lu CP; Lee WJ; Ho MM; Hwang KC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(3):173-80. PubMed ID: 8368064
[TBL] [Abstract][Full Text] [Related]
36. The Harada score in the US population of children with Kawasaki disease.
Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
[TBL] [Abstract][Full Text] [Related]
37. Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease.
Nagatomo Y; Muneuchi J; Nakashima Y; Nanishi E; Shirozu H; Watanabe M; Uike K; Nagata H; Hirata Y; Yamamura K; Takahashi Y; Okada S; Suzuki Y; Hasegawa S; Ohga S
Int J Cardiol; 2018 Nov; 271():317-321. PubMed ID: 30144998
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
[TBL] [Abstract][Full Text] [Related]
39. Prescribing patterns of coronary artery aneurysm in Taiwan.
Lu CH; Fang CW; Chen HM; Fang YP; Fang CT; Huang YB; Chen CY; Liao KM; Yeh SJ
BMC Cardiovasc Disord; 2019 Aug; 19(1):188. PubMed ID: 31382884
[TBL] [Abstract][Full Text] [Related]
40. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
Bachlava E; Loukopoulou S; Karanasios E; Chrousos G; Michos A
Int J Cardiol; 2016 Oct; 220():65-9. PubMed ID: 27372045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
